Annals of Vascular Diseases

metrics 2024

Connecting Ideas, Advancing Vascular Treatments

Introduction

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor0.60
Journal Impact Factor (5 years)0.80
H-Index-
Journal IF Without Self0.60
Eigen Factor0.00
Normal Eigen Factor0.19
Influence0.26
Immediacy Index0.10
Cited Half Life6.20
Citing Half Life9.30
JCI0.15
Total Documents-
WOS Total Citations719
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 86/96
Percentile 10.90
Quartile Q4

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 85/96
Percentile 11.46
Quartile Q4

Quartile History

Similar Journals

CVIR Endovascular

Bridging Clinical Practice and Imaging Techniques for Better Outcomes
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

CVIR Endovascular is a pioneering journal published by SPRINGERNATURE, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. Established as an Open Access platform since 2018, this journal has become increasingly pivotal for disseminating high-quality research that bridges clinical practice and innovative imaging techniques. With a robust focus on minimally invasive therapies and advancements in endovascular procedures, CVIR Endovascular serves as an essential resource for researchers, professionals, and students alike. The journal is indexed in key databases and holds notable rankings within its categories, specifically achieving Q3 quartile status in both Cardiology and Cardiovascular Medicine and Radiology for 2023. This positions it as an influential publication in the ever-evolving landscape of cardiovascular research. As it converges through the years from 2018 to 2024, CVIR Endovascular continues to strive for excellence, aiming to provide a platform for innovative findings and best practices that can enhance the future of endovascular care.

EJVES Vascular Forum

Exploring New Frontiers in Vascular Surgery
Publisher: ELSEVIERISSN: 2666-688XFrequency:

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

Jornal Vascular Brasileiro

Fostering Collaboration in Cardiovascular Innovation.
Publisher: SOC BRASILEIRA ANGIOLOGIA CIRURGIA VASCULAR-SBACVISSN: 1677-5449Frequency: 1 issue/year

Jornal Vascular Brasileiro is a prestigious Open Access journal published by the SOC BRASILEIRA ANGIOLOGIA CIRURGIA VASCULAR-SBACV and dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Since its inception in 2005, this Brazilian journal aims to provide a platform for sharing innovative research, clinical practices, and reviews that address the complexities of vascular health. With an ISSN of 1677-5449 and an E-ISSN of 1677-7301, it has emerged as a vital resource for researchers, practitioners, and students alike, despite its current positioning in the Q4 quartile for its category in 2023, reflecting a commitment to scholarly rigor and growth. The journal invites contributions on a wide range of topics, making it an essential reading for those involved in the academic study and clinical application of vascular medicine. As we look towards 2024, Jornal Vascular Brasileiro continues to bridge local and global perspectives, fostering collaboration and innovation in cardiovascular research and practice.

JOURNAL OF CARDIOVASCULAR SURGERY

Transforming cardiovascular surgery through knowledge.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0021-9509Frequency: 6 issues/year

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Advancing cardiovascular knowledge through groundbreaking research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Italian Journal of Vascular and Endovascular Surgery

Exploring new frontiers in vascular research and practice.
Publisher: EDIZIONI MINERVA MEDICAISSN: 1824-4777Frequency: 4 issues/year

Italian Journal of Vascular and Endovascular Surgery, published by EDIZIONI MINERVA MEDICA, serves as a pivotal platform in the realm of vascular and endovascular surgical research in Italy and beyond. With an ISSN of 1824-4777 and an E-ISSN of 1827-1847, this journal spans a decade of scholarly contributions from 2004 to 2024. Although currently categorized in the Q4 quartile within both Cardiology and Cardiovascular Medicine and Surgery, with Scopus ranks reflecting its growing recognition in the scientific community, it continues to foster advancements in the understanding and treatment of vascular diseases. The journal is dedicated to publishing innovative research, clinical studies, and comprehensive reviews that empower professionals and enrich the education of students in the vascular surgery field. While currently not offering open access, it remains an essential resource for those seeking to stay abreast of the latest developments and practices in vascular and endovascular surgery.

INTERNATIONAL ANGIOLOGY

Elevating Cardiovascular Medicine with Cutting-Edge Insights
Publisher: EDIZIONI MINERVA MEDICAISSN: 0392-9590Frequency: 6 issues/year

INTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.

JOURNAL OF ENDOVASCULAR THERAPY

Unlocking New Horizons in Endovascular Procedures
Publisher: SAGE PUBLICATIONS INCISSN: 1526-6028Frequency: 6 issues/year

Journal of Endovascular Therapy, published by SAGE Publications Inc., has established itself as a leading source of research and innovation in the fields of Cardiology, Cardiovascular Medicine, Radiology, and Surgery. With an impressive impact factor and recognized in the Q1 quartile for its contributions, this journal is essential for professionals and researchers dedicated to advancing the practice of endovascular therapy. The journal, which has been in circulation since 2000, covers a wide range of topics pertinent to endovascular procedures and therapeutics, offering valuable insights and findings that drive clinical practice and enhance patient outcomes. With its emphasis on high-quality peer-reviewed content, the Journal of Endovascular Therapy serves as a vital resource for both established experts and emerging scholars in the medical community. Access to the journal is facilitated for a wider audience, ensuring that innovative research reaches practitioners and academics worldwide, fostering an environment of collaboration and knowledge exchange.

PHLEBOLOGIE

Transforming Vascular Insights into Clinical Practice
Publisher: GEORG THIEME VERLAG KGISSN: 0939-978XFrequency: 6 issues/year

PHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.

Vascular

Connecting research and practice for vascular excellence.
Publisher: SAGE PUBLICATIONS LTDISSN: 1708-5381Frequency: 6 issues/year

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.